Skoči na glavni sadržaj

Studija slučaja

Use of Esketamine Combined with Dexmedetomidine for Difficult Tracheal Intubation in an Uncooperative Pediatric Patient with Severe Trismus: A Case Report

Jue Jiang ; Department of Anesthesiology, Shanghai 9th People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China *
Guifang Yu orcid id orcid.org/0009-0003-6212-8122 ; Department of Anesthesiology, Shanghai 9th People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China

* Dopisni autor.


Puni tekst: engleski pdf 3.895 Kb

str. 60-64

preuzimanja: 0

citiraj


Sažetak

Managing difficult airways in pediatric patients with severe trismus and poor cooperation is challenging because conventional sedatives may suppress spontaneous respiration. We report a case of a 15-year-old girl (weight 50 kg) with recurrent rhabdomyosarcoma causing severe trismus (0-finger mouth opening) and facial deformity. After premedication with atropine and methylprednisolone, sedation was achieved with a slow infusion of dexmedetomidine (20 μg over 10 minutes) followed by intravenous esketamine (20 mg, 0.4 mg/kg). This regimen preserved spontaneous breathing with oxygen saturation maintained at 99–100% throughout the procedure. Topical anesthesia of the nasopharynx was performed using 2% lidocaine spray (total dose 100 mg, approximately 2 mg/kg) via spray-as-you-go technique. Fiberoptic nasotracheal intubation was then successfully accomplished without coughing, body movement, or hemodynamic instability. No adverse events such as emergence reactions or hallucinations occurred. This multimodal sedation approach may offer a safe and effective alternative when preserving spontaneous respiration is critical in uncooperative pediatric patients with severely restricted mouth opening.

Ključne riječi

Airway Management; Child; Dexmedetomidine; Esketamine; Fiberoptic Intubation; Rhabdomyosarcoma; Trismus

Hrčak ID:

348901

URI

https://hrcak.srce.hr/348901

Datum izdavanja:

6.7.2026.

Posjeta: 0 *